Quantification of "Mercy Sex" in Heterosexual Women.

This paper introduces and quantifies the concept of "mercy sex" — defined as sexual activity engaged in by women diagnosed with hypoactive sexual desire disorder (HSDD) despite a documented absence of sexual desire or receptivity. The authors reviewed baseline data on sexually satisfying events (SSEs) drawn from a convenience sample of published, peer-reviewed, prospective, randomized, placebo-controlled clinical trials evaluating HSDD pharmacotherapies (including testosterone, flibanserin, and bremelanotide) conducted over nearly a decade. Baseline SSE data were analyzed across variables including time, age, reproductive status, and geographic region. The study found that women enrolled in these trials reported engaging in sexual activity approximately 2.5 times per month at baseline, despite meeting criteria for HSDD. The authors propose biopsychosocial explanations for this behavior and argue that mercy sex may confound HSDD trial outcomes by inflating baseline SSE rates, potentially skewing assessments of therapeutic efficacy, influencing sample size calculations, and complicating the definition of a clinically meaningful treatment response when SSEs serve as a primary endpoint. Limitations include reliance on secondary analysis of existing trial data and the use of a convenience sample. The paper does not conduct a new primary trial but offers a methodological and conceptual critique of HSDD clinical research design.

Why this grade: This is a secondary analysis and conceptual review of existing RCT baseline data rather than an original primary trial, limiting its ability to independently establish causal or efficacy claims.